CAR T-Cell Therapy – Advancing the Frontiers of Cancer Care
At Kauvery Hospital, we are proud to introduce CAR T-Cell Therapy, a revolutionary advancement in cancer treatment. With this cutting-edge, personalized therapy, we empower your immune system to recognize and destroy cancer cells with unprecedented precision. This is not just a treatment — it is a beacon of hope for patients with certain cancers who have exhausted conventional therapies.
What is CAR T-Cell Therapy?
CAR T-Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy) is an immunotherapy that harnesses your body’s natural defense system — the immune system — and supercharges it to target cancer cells more effectively.
Unlike traditional treatments such as chemotherapy and radiation, CAR T-Cell Therapy is a living therapy. It uses specially engineered T-cells (a type of white blood cell) to hunt down and eliminate cancer cells with surgical precision, while sparing healthy cells to a large extent.
The CAR T-Cell Therapy Process at Kauvery Hospital
Our multidisciplinary team of haematologists, oncologists, and immunotherapy experts carefully evaluate your medical history, diagnosis, and overall health to determine if CAR T-Cell therapy is suitable for you.
Your T-cells are collected from your blood using a special process called leukapheresis. This is similar to a blood donation and is painless and safe.
In collaboration with globally accredited laboratories, your collected T-cells are genetically modified to express CARs. These cells are then multiplied to produce millions of potent CAR T-cells.
Before infusing the CAR T-cells back into your body, you may receive a short course of lymphodepleting chemotherapy to create space for the new cells to work effectively.
The engineered CAR T-cells are infused back into your bloodstream — a simple, outpatient procedure similar to a blood transfusion.
After infusion, you will be closely monitored by our expert team for several weeks to ensure your safety, manage side effects, and assess treatment response.
Which Cancers Can CAR T-Cell Therapy Treat?
At present, CAR T-Cell Therapy has been approved for treating:
- B-cell Acute Lymphoblastic Leukemia (ALL) — in children and young adults
- Diffuse Large B-cell Lymphoma (DLBCL)
- Mantle Cell Lymphoma (MCL)
- Multiple Myeloma
Clinical trials and research are ongoing to expand CAR T-Cell therapy to other cancers such as chronic lymphocytic leukemia (CLL) and even solid tumors.
Book an Appointment
Why Choose Kauvery Hospital for CAR T-Cell Therapy?
State-of-the-Art Cellular Therapy Facility
Advanced infrastructure designed for safe T-cell collection, processing, infusion, and patient care.
Multidisciplinary Expert Team
Highly experienced hematologists, oncologists, immunologists, critical care specialists, and specialized nurses collaborate to deliver comprehensive care.
Global Collaborations and Accreditation
We follow internationally benchmarked protocols, ensuring the highest standards of cellular therapy.
Holistic Patient Care
Beyond the therapy, we provide emotional, psychological, nutritional, and rehabilitation support to enhance recovery and quality of life.
Compassionate Approach
We believe in treating not just the disease but the individual — with empathy, dignity, and respect.
Frequently Asked Questions
CAR T-Cell Therapy is an advanced immunotherapy that re-engineers a patient’s own T-cells to recognize and destroy cancer cells with precision.
Unlike chemotherapy and radiation, CAR T-Cell Therapy is a living therapy that uses modified T-cells to target cancer cells while sparing most healthy cells.
Currently, CAR T-Cell Therapy is approved for B-cell Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Multiple Myeloma.
The process includes evaluation, T-cell collection, engineering and expansion, preconditioning chemotherapy, infusion of CAR T-cells, and close monitoring.
No. The infusion is like a blood transfusion and is generally painless and safe.
Benefits include high response rates, potential long-term remission, single-infusion treatment, minimal invasiveness, and a personalized approach.
Kauvery offers a state-of-the-art cellular therapy facility, a multidisciplinary expert team, global collaborations, holistic patient care, and a compassionate approach.
What are the Benefits of CAR T-Cell Therapy?
- High Response Rates in eligible patients, even when other treatments have failed
- Single Infusion Therapy — most patients need only one infusion
- Potential for Long-Term Remission
- Minimally Invasive and Personalized
Kauvery Hospital — Where Advanced Science Meets Compassionate Care
